Meghmani Organics Limited filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, on August 14, 2026. The filing details the company’s environmental, social, and governance (ESG) performance, highlighting a rise in renewable energy adoption and safety improvements across its operations.

Key Financial and Operational Metrics

The report discloses a turnover of ₹2,091.8 crore and a net worth of ₹1,758.3 crore for FY26. Meghmani Organics operates seven plants and one office in India, with two international offices in China and the USA. Exports account for 85.2% of total turnover, serving customers in 75 countries.

Environmental Performance

Renewable electricity contributed 41.8% of total electricity consumption in FY26, up from 39.03% in FY25. The company achieved 2,000 MWh of energy savings through process optimization and utility efficiency initiatives. Meghmani Organics aims to reduce Scope 1 emissions by 10% and Scope 2 emissions by 12% by FY29-30.

The company secured an EcoVadis Silver Rating, placing it in the top 15% of globally assessed companies. It also achieved ISO 27001 for information security and ISO 37001 for anti-bribery management during the year.

Social and Governance Highlights

Meghmani Organics employs 1,330 permanent employees and 1,672 workers. Female representation stands at 1.28% among permanent employees and 0.9% among workers. The board includes one female director, representing 10% of the total.

Safety metrics showed zero fatalities across all operating sites. The Total Recordable Injury Rate (TRIR) was reported as 0.25 in FY26, compared to 0.38 in FY25. The company maintained zero incidents of bribery, corruption, or regulatory non-compliance.

What the Numbers Show

The divergence between high export revenue (85.2% of turnover) and limited international physical presence (two offices) indicates a reliance on distributed supply chains and third-party logistics rather than direct foreign manufacturing assets. This structure necessitates robust supplier ESG assessments, which the company expanded to cover 100% of onsite vendors and contractors.

Meghmani Organics delivered a strong financial performance for the fiscal year ended March 31, 2026, driven by improved product mix and operational efficiencies. The chemical manufacturer reported a standalone profit after tax (PAT) of ₹125.3 crore, a substantial rise from ₹66.4 crore in FY25. On a consolidated basis, the group returned to profitability, recording a positive PAT of ₹28.7 crore, compared to a loss of ₹10.6 crore in the preceding year.

Financial Highlights

The company’s standalone revenue from operations stood at ₹2,091.8 crore, reflecting steady growth despite challenging market conditions characterized by geopolitical tensions and rising raw material costs. Earnings before interest, taxes, depreciation, and amortization (EBITDA) expanded by 27% year-on-year to ₹228.7 crore.

On a consolidated basis, revenue reached ₹2,174.0 crore, with EBITDA growing by 24% to ₹176.4 crore. The improvement in profitability was attributed to disciplined execution, cost management, and an optimized product mix across its key segments.

Segment Performance

The Crop Protection segment remained the primary growth engine, contributing approximately 78% of the total standalone revenue. This segment saw a substantial improvement in EBITDA, driven by an enriched product mix that included higher-value formulations. The Pigments segment, constituting roughly 22% of standalone revenue, reported a positive EBITDA, benefiting from product-mix optimization and cost-reduction initiatives.

Strategic Developments

During the year, Meghmani Organics established a wholly owned subsidiary in Brazil, aiming to strengthen its presence in one of the world’s largest agrochemical markets. The company also received approvals for manufacturing Nano DAP, Nano NPK, and Nano Zinc fertilizers, reinforcing its position in the sustainable crop nutrition space.

Furthermore, the Board approved a Scheme of Amalgamation to merge its wholly owned subsidiaries, Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited, into the parent company. This move is intended to simplify the group structure, achieve operational synergies, and reduce administrative costs.

Balance Sheet and Dividend

The company maintained financial prudence, reducing its debt by approximately ₹160 crore during the year. As of March 31, 2026, the consolidated debt-to-equity ratio stood at 0.47x. Cash and cash equivalents decreased to ₹1,282.2 lakh from ₹1,866.5 lakh in the previous year.

In line with its strategy to conserve profits for reinvestment and balance sheet strengthening, the Board did not recommend any dividend for FY26.

What the Numbers Show

The divergence between the standalone and consolidated results highlights the impact of subsidiary performance on the group's bottom line. While the parent entity achieved a robust standalone PAT of ₹125.3 crore, the consolidated PAT was significantly lower at ₹28.7 crore. This gap is largely attributable to the losses incurred by subsidiaries, particularly Kilburn Chemicals Limited, which faced pressure from elevated raw material costs and weaker price realizations in the Titanium Dioxide segment. The proposed amalgamation aims to address these structural inefficiencies.